A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies
Abroad (travel likely)Recruiting
Conditions
Ulcerative Colitis · Inflammatory Bowel Diseases
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Central Hospital, Nancy, Lorraine, France
Contact: Study coordinator (Laurent MD PEYRIN-BIROULET, PhD)
Study leads
Stefan MD SCHREIBER, PhD
Study Director
Christian Albrechts Universität